PCME is an accredited provider specializing in innovative continuing medical education solutions.
PCME is an accredited provider specializing in innovative continuing medical education solutions.
In 2007, an estimated 178,480 women and 2,030 men were diagnosed with breast cancer and more than 40,460 died from the disease. Ovarian cancer is less common, but the mortality rate is very high, with 22,430 new cases and 15,280 deaths in 2007. For both cancers, early detection and management can significantly improve survival; however, most women remain undiagnosed until they have advanced disease.
Oncology nurses are critical in the clinical management of advanced disease through their influence on treatment decisions and management of side effects. With the introduction of new chemotherapeutic and biologic agents given in a variety of combinations and schedules, oncology nurses must recognize potential side effects and consider additive toxicities. In addition to the role of managing patients, the oncology nurse also helps to recognize patients and family members at high-risk for breast and ovarian cancers. Understanding the principles of hereditary breast and ovarian cancer, as well as the basic principles of risk assessment and management, will allow the oncology nurse to effectively evaluate and manage patients at risk, and counsel patients and family members to ultimately improve outcomes.
This CE Webcourse will examine the therapeutic challenges of advanced breast cancer and refractory ovarian cancer through case presentations and discuss the implications for hereditary breast and ovarian cancer risk assessment and management.
Requirements: This program requires a working internet connection and a web browser supporting cookies, javascript, and Adobe Flash™ version 9 or higher. Click here to download Flash.
| Faculty | Faculty Disclosures | |
 |
Karen Roesser, RN, MSN, AOCN (Chairperson) Oncology Clinical Nurse Specialist Thomas Johns Cancer Center CJW Medical Center Richmond, VA |
Karen Roesser, RN, MSN, AOCN Consultant: Myriad Genetic Labs |
 |
Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP Assistant Clinical Professor University of California, San Francisco Oncology Nurse Practitioner Camino Medical Group San Francisco, CA |
Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP Speaker: Amgen, BMS, Novartis, Merck, Imer, Meniscus |
 |
Rebecca Hawkins, MSN, ANP Palliative Care and Oncology Nurse Practitioner St. Mary Medical Center Walla Walla, WA |
Rebecca Hawkins, MSN, ANP Speaker: Novartis, ONS Edge, Excellence in |
This program was developed for oncology nurses and nurse practitioners.
At the conclusion of this activity, participants should understand and demonstrate the ability to:
CME Consultants is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
CME Consultants designates this program for 1.25 contact hour(s). Participants should claim only those contact hours actually spent in the educational activity.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
In direct response to the September 2004 Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, CME Consultants issued a conflict of interest policy dated January 2, 2005. The policy states that the disclosure of potential financial conflicts of interest within the last 12 months must be made and resolved prior to date of the CME/CE activity where commercial support grants are to be used to fund the activity. The following conflicts have been managed and resolved through CME Consultants Independent Review Committee. Our intent is to assist learners in assessing the potential for bias in information that is presented during the CME/CE activity.
The faculty is also aware it is their responsibility to inform the audience if discussion of any non - FDA approved uses of pharmaceutical, medical equipment, prostheses, etc. will be included in their presentation.
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
The following staff members of the Potomac Center for Medical Education involved in the development of content for this activity disclosed that they have no relevant financial relationships: Laurie Frueh, MD, Medical Science Liaison, Kathy Merlo, Medical Writer, Donna Fucello, Vice President, Clinical Education Division & Accreditation Services, Blair St. Amand, Editor, Dana Simpler, MD, external medical reviewer.
The following staff members of CME Consultants involved in the development of content for this activity disclosed that they have no relevant financial relationships: Samantha Mattiucci, PharmD, Medical Director/Managing Director, Jennifer Furlong, Senior Project Manager.
The contents of some CME/CE activities may contain discussions of nonapproved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
Estimated time frames for completion of the Webcourse activity, post test and evaluation will take approximately 1.50 hours.
Jointly Sponsored by 
Supported by an educational grant from 
By clicking this button you are agreeing that you have read and understood the CME Statements above
